Hanmi Pharm to split into holding, operating companies

Published: 2010-06-01 06:59:00

Updated: 2010-06-01 06:59:00

Hanmi Pharm Co., a Korean drugmaker, said on May 28 that it will split into holding and operating entities to simplify its corporate structure and boost investor interest,.

Hanmi Pharm will be separated into two firms -- a holding company tentatively named Hanmi Holdings Co. and an operating ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK